Search results
Study reveals persistent risk of death, symptoms in COVID survivors at 3 years
Center for Infectious Disease Research and Policy· 5 days agoCOVID-19 patients hospitalized with the wild-type virus in 2020 were at a 29% higher risk for death...
Thousands of Patients to Be Given World's First Cancer Vaccine
Futurism via Yahoo News· 4 days agoThe United Kingdom's National Health Service (NHS) is fast-tracking patients for its game-changing...
COVID patients at higher risk for respiratory complications well after infection, study finds
Center for Infectious Disease Research and Policy· 7 days agoThe risks of respiratory complications were eightfold and nearly twofold greater in COVID-19...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion By Reuters
Investing.com· 6 days agoLondon-based EyeBio, which operates as Eyebiotech Ltd, has operations in the United States and the...
Fauci admits he 'never' read research grant applications before approving them
Just the News· 4 days agoRepublicans released some tidbits soon after Fauci's interview in January, including his admission...
RFK Jr.'s VP choice ties herself to Tucker Carlson during Kittery rally
WCSH 6 Portland· 4 days agoRobert F. Kennedy Jr.’s vice presidential pick, Nicole Shanahan, held a rally in Maine Thursday in...
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 6 hours agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Researchers take step toward development of universal COVID-19 antibodies
telegraphherald.com· 5 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium ...
Researchers are working on a new mRNA vaccine—this time for bird flu
Fast Company Magazine· 7 days agoConcerns about bird flu continue to grow as a new deadly subtype spreads among wild animals and...
CDMOs: The Tool That Turns A Hope Into A Cure
International Business Times· 21 hours agoThe number of CDMOs greatly increased during the Covid-19 pandemic, but Batavia is no newcomer. Batavia provides tailored experiences in process...
